From July 12, 2021 to September 30, 2021, the company has repurchased 0 shares, representing 0% for CAD 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CAD 0 million under the buyback announced on July 12, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.72 CAD | -1.72% | -2.39% | +10.21% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.21% | 422M | |
+4.48% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+22.11% | 2.55B | |
-28.33% | 2.24B | |
-24.15% | 2.26B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Tranche Update on Knight Therapeutics Inc.'s Equity Buyback Plan announced on July 12, 2021.